Bank Of America Corp Oyster Point Pharma, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$7.95 - $11.68 $19,032 - $27,961	-2,394 Reduced 17.8%	11,057 $123,000
Q3 2022 Nov 14, 2022	SELL	$4.41 - $8.38 $15,077 - $28,651	-3,419 Reduced 20.27%	13,451 $76,000
Q2 2022 Aug 12, 2022	SELL	$3.6 - $11.2 $27,694 - $86,161	-7,693 Reduced 31.32%	16,870 $73,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $32,063 - $65,958	-3,737 Reduced 13.2%	24,563 $286,000
Q4 2021 Feb 08, 2022	BUY	$10.17 - $18.96 $249,897 - $465,885	24,572 Added 659.12%	28,300 $517,000
Q3 2021 Nov 15, 2021	SELL	$11.67 - $18.07 $5,531 - $8,565	-474 Reduced 11.28%	3,728 $45,000
Q2 2021 Sep 13, 2021	BUY	$16.25 - $21.51 $68,282 - $90,385	4,202 New	4,202 $72,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.